Genetic factors associated with prostate cancer conversion from active surveillance to treatment-Reference-Cited by-同舟云学术

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Published:2022-01 Issue:1 Volume:3 Page:100070
ISSN:2666-2477
Container-title:Human Genetics and Genomics Advances
language:en
Short-container-title:Human Genetics and Genomics Advances

Author:

Jiang Yu^ORCID,Meyers Travis J.,Emeka Adaeze A.,Cooley Lauren Folgosa,Cooper Phillip R.,Lancki Nicola,Helenowski Irene,Kachuri Linda,Lin Daniel W.,Stanford Janet L.,Newcomb Lisa F.,Kolb Suzanne,Finelli Antonio,Fleshner Neil E.,Komisarenko Maria,Eastham James A.,Ehdaie Behfar,Benfante Nicole,Logothetis Christopher J.,Gregg Justin R.,Perez Cherie A.,Garza Sergio,Kim Jeri,Marks Leonard S.,Delfin Merdie,Barsa Danielle,Vesprini Danny,Klotz Laurence H.,Loblaw Andrew,Mamedov Alexandre,Goldenberg S. Larry,Higano Celestia S.,Spillane Maria,Wu Eugenia,Carter H. Ballentine,Pavlovich Christian P.,Mamawala Mufaddal,Landis Tricia,Carroll Peter R.,Chan June M.,Cooperberg Matthew R.,Cowan Janet E.,Morgan Todd M.,Siddiqui Javed,Martin Rabia,Klein Eric A.,Brittain Karen,Gotwald Paige,Barocas Daniel A.,Dallmer Jeremiah R.,Gordetsky Jennifer B.,Steele Pam,Kundu Shilajit D.,Stockdale Jazmine,Roobol Monique J.,Venderbos Lionne D.F.,Sanda Martin G.,Arnold Rebecca,Patil Dattatraya,Evans Christopher P.,Dall’Era Marc A.,Vij Anjali,Costello Anthony J.,Chow Ken,Corcoran Niall M.,Rais-Bahrami Soroush,Phares Courtney,Scherr Douglas S.,Flynn Thomas,Karnes R. Jeffrey,Koch Michael,Dhondt Courtney Rose,Nelson Joel B.,McBride Dawn,Cookson Michael S.,Stratton Kelly L.,Farriester Stephen,Hemken Erin,Stadler Walter M.,Pera Tuula,Banionyte Deimante,Bianco Fernando J.,Lopez Isabel H.,Loeb Stacy,Taneja Samir S.,Byrne Nataliya,Amling Christopher L.,Martinez Ann,Boileau Luc,Gaylis Franklin D.,Petkewicz Jacqueline,Kirwen Nicholas,Helfand Brian T.,Xu Jianfeng,Scholtens Denise M.,Catalona William J.,Witte John S.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Genetics (clinical),Molecular Medicine

Reference86 articles.

1. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US;Washington;JAMA Netw. Open,2020

2. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Mohler;J. Natl. Compr. Canc. Netw.,2019

3. Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015;Loeb;JAMA,2018

4. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018;Parikh;JAMA Netw. Open,2020

5. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden;Loeb;JAMA Oncol.,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomics in active surveillance and post-prostatectomy patients: A review of when and how to use effectively;Current Urology Reports;2024-06-13

2. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer;Journal of Urology;2024-06

3. Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology;JCO Precision Oncology;2024-02

4. Biochemical interaction of twenty steroid derivatives with ribosomal protein kinase 4 S6 (RSK-4) surface using a theoretical model;Brazilian Journal of Science;2024-02-01

5. Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification;Journal of Urology;2023-12-26